Professor/Associate Professor/Senior Lecturer of Gene Therapy

Please specify in your application form which level of appointment you are applying for - Professor, Associate Professor or Senior Lecturer.

This is an exciting opportunity for an individual with world leading expertise in gene therapies to join the £22m National Horizon Centre (NHC).

At the National Horizons Centre, high-quality research activity is undertaken with a strong industry focus, linking advanced biosciences to an understanding of whole bioprocesses by which discoveries are translated into healthcare outcomes.

The NHC has superb facilities for gene therapy research with potential for significant impact on the biosciences and healthcare sector. The Centre’s research portfolio spans biotechnology and analytics, bioinformatics and data science, and health and disease.

Working in partnership with healthcare providers we identify the current medical needs across a range of diseases, using cutting-edge genomics, next-generation sequencing, and proteomic approaches.
To create the most impact possible, and achieve the desired outcomes for society, we collaborate with the best scientists and clinicians in the bioscience and healthcare sector. This is reinforced through our strategic partnerships.

Our Northern Bio-Accelerator Partnership (NBioP) with CPI and FUJIFILM Diosynth Biotechnologies, creates a bioprocessing, biomanufacturing and biopharmaceutical hub making the North East a centre of innovation, with expertise in the full life cycle of biopharmaceuticals, from basic and applied bioprocessing research, through to biopharmaceutical scale up and ultimately, the commercial manufacture of life changing medicines. More information here.

Our partnership with the NHS, via the Durham Tees Valley Research Alliance (DTVRA), looks to explore new ways in which the two organisations can harness their world-leading research expertise to deliver real impact in healthcare, through clinical and biomedical research, joint grant applications, supporting research fellowships, co-supervising PhD studentships, and access to the NHC’s training courses for healthcare professionals. More information here.

Our THYME project is a collaboration between the Universities of Teesside, Hull and York to establish a world-leading bioeconomy region across Yorkshire, Humberside and the Tees Valley. This project is funded by Research England via its Connecting Capability Fund. More information here.

We are also a UK National Training Centre for Advanced Therapies, providing essential hands-on training courses in advanced therapies, vaccine manufacturing and bioprocessing. More information here.

We are now seeking a new member of staff to strengthen the role of gene therapies, that underpin our health and disease research and biomanufacturing research. Experience in upstream production of viral vectors or non-viral vectors (viral like particles, liposomes etc.) and their manufacturing or development of downstream purification tools is desirable.

The track record could be demonstrated through strong translational research particularly involvement in clinical studies related to gene therapy products for various chronic degenerative diseases such as muscular atrophies, hereditary disorders, various types of cancers and immunologic disorders.

Working within the NHC you will grow our research portfolio with a strong industrial focus. You will develop a programme of externally funded research and contribute to the research, and enterprise objectives of the NHC and Teesside University. You will have a strong track record of publishing in high impact peer-reviewed journals and securing funding from a range of sources, including industrial partners.